Adjuvant Abemaciclib Combined with Endocrine Therapy (ET): Efficacy Results in monarchE Cohort 1
MonarchE efficacy presentation from ESMO Breast Cancer 2022, Berlin
Licensed with permission from the European Society for Medical Oncology (ESMO). All rights reserved.
The mention of any company, product, service, or therapy in this collection of materials does not constitute an endorsement of any kind by ESMO.